HOST: Andy Herber, P.A.-C.
GUEST: Ronald S. Go, M.D.
Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to provid ... Show More
Jan 20
Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"
Host: Darryl S. Chutka, M.D. Guest: Stephen Kopecky, M.D. One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown signi ... Show More
26m 17s
Jan 15
Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"
Host: Darryl S. Chutka, M.D. Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss ... Show More
24m 22s
Jan 13
Rx for Weight Loss: A Closer Look Series "Importance of Lifestyle Changes with Use of GLP-1 Medications"
Host: Darryl S. Chutka, M.D. Guest: Tamim Rajjo, M.D., M.P.H. Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have f ... Show More
26m 2s
Oct 2023
212. Big Red - An Approach to Macrocytic Anemia
<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/149353/open_sms">Send us a text</a></p><p>In this episode, we review the etiologies, pathophysiology, investigations and management of macrocytic anemia. Our medicine minute addresses how to best suppleme ... Show More
12m 21s
May 2024
May 10 2024 This Week in Cardiology
<p>Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To rea ... Show More
31m 56s
Jun 2023
June 2 This Week in Cardiology
<p>Listener feedback on the most important study in a decade, MONITOR-HF, a flawed paper and analysis, and the tension between pathos and logos are the topics John Mandrola, MD discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only ... Show More
27m 47s
May 2022
208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry Jackson
Atrial fibrillation may reach pandemic proportions in the next 2-3 decades. Factors that drive this phenomenon have been studied in predominantly White populations, leading to a significant underrepresentation of certain racial/ethnic groups in atrial fibrillation epidemiological ... Show More
38m 36s
May 2023
May 26 2023 This Week in Cardiology
<p>An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>. ... Show More
31m 32s
Feb 2021
Episode 158: WDx #7 – Clinical Unknown with Dr. Jori May – Vaginal Bleeding
Maani, Priyanka, and Lindsey discuss a clinical unknown with Dr. Jori May. Want to test your learning? Take our episode quiz here Dr. Jori May Jori May, MD, is Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham (UAB). ... Show More
51m 16s
<p><strong>Contributor: Meghan Hurley, MD</strong></p> <p><strong>Educational Pearls:</strong></p> <ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">Syncope is defined as a loss of consciousness with an immediate return to baseline</span></li> <li ... Show More
